Canada VC Funds

NewSpring Capital, founded in 1999 and headquartered in Radnor, Pennsylvania, is a private equity firm focusing on growth equity, mezzanine capital, healthcare, and buyouts. The firm manages approximately $3.5 billion in assets and has invested in over 250 companies across various sectors. Notable investments in NewSpring's portfolio include Vacasa, a leading vacation rental management company; Innovid, a video marketing platform; and Nutrisystem, a weight management company. These investments reflect NewSpring's strategy of supporting high-growth companies in business services, healthcare, information technology, and consumer products. NewSpring Capital operates through multiple strategies, including NewSpring Growth, which targets high-growth technology companies; NewSpring Healthcare, focusing on innovative healthcare services and technology; and NewSpring Mezzanine, providing capital for acquisitions and recapitalizations. The firm's comprehensive approach allows them to support companies at different stages of their lifecycle, from early growth to expansion.

New Venture Partners is a global venture capital firm that specializes in transforming corporate R&D assets into standalone businesses. The firm focuses on leveraging cutting-edge innovations from large technology companies and spinning them out into independent ventures. With a unique approach, New Venture Partners works closely with corporate partners to identify high-potential technologies that may not align with the company's core business but have significant market opportunities. The firm invests primarily in sectors such as telecommunications, IT, semiconductors, and digital media, emphasizing deep tech and transformative innovations. Their portfolio includes companies that emerged from major R&D labs, such as Bell Labs and British Telecom, showcasing their expertise in corporate spinouts. New Venture Partners typically invests in early-stage startups, guiding them from the incubation phase through to commercialization. Their team brings a wealth of experience from both the corporate and entrepreneurial worlds, providing a mix of strategic guidance and operational support to help ventures scale. With offices in the U.S. and Europe, New Venture Partners has a global reach and focuses on markets across both continents. Their strategy revolves around aligning with corporate partners to unlock the commercial potential of underutilized technologies, ultimately creating high-value businesses that deliver strong financial returns. The firm has established a reputation as a leader in corporate venture capital, with a track record of successful exits and long-term value creation.

Credit Suisse Entrepreneur Capital Ltd., established in 2010, is the venture capital arm of Credit Suisse based in Zurich, Switzerland. The firm focuses on investing in innovative small and medium-sized enterprises (SMEs) and startups across various sectors, including robotics, automation, medtech, and fintech. To date, Credit Suisse Entrepreneur Capital has invested around CHF 130 million in over 50 companies, and recently expanded its fund by an additional CHF 70 million, bringing the total to CHF 200 million. Notable investments from Credit Suisse Entrepreneur Capital include Perspective Robotics (d.b.a. Fotokite), a Zurich-based startup specializing in tethered drones that improve the safety and efficiency of public safety operations, and Ava, a company in the monitoring equipment sector. These investments highlight the firm’s commitment to supporting high-potential technologies and innovative business models. Credit Suisse's venture capital efforts are part of a broader strategy to support Switzerland's entrepreneurial ecosystem, ensuring the country remains a global leader in innovation and business. For more information about their investments and strategic approach, you can visit their official website.

NextGen Venture Partners is a unique venture capital firm that leverages a network-driven approach to investing. Founded in 2012 and based in Baltimore, Maryland, the firm collaborates with over 1,800 Venture Partners to support early-stage and growth-stage companies across various industries in the US​. NextGen typically invests between $1 million to $2 million in seed-stage companies and $3 million to $5 million in growth-stage companies that have $10 million+ in revenue. Their network of Venture Partners, consisting of top entrepreneurs and executives, provides startups with valuable connectivity for sales, hiring, and financing introductions, as well as on-demand advice. The firm's leadership team includes Managing Partners Jon Bassett, Ben Bayat, Brett Gibson, and Chris Keller, along with other experienced professionals like Deborah Chu (Principal) and Corinne Smeriglio (Director of Operations)​. This team brings decades of combined experience in investing and building companies.

NextView Ventures is a venture capital firm specializing in seed-stage investments, focusing on companies that use technology to drive the "Everyday Economy." This includes sectors where people spend significant time, money, and attention. The firm was established in 2011 and operates out of Boston and New York City, with a commitment to backing companies from the concept stage. Notable investments by NextView Ventures include companies such as ThredUp, WHOOP, Attentive, Grove Collaborative, and Skillz. ThredUp, an online fashion resale platform, went public on NASDAQ in 2021. WHOOP, a wearable fitness tracker, has become a significant player in the market, valued at over $3.6 billion. Attentive, an SMS marketing platform, serves over 4,000 e-commerce customers and significantly drives their revenue. NextView Ventures recently closed its fourth fund at $100 million, continuing its high-conviction, hands-on seed strategy. The firm targets the full seed spectrum, from pre-launch and pre-seed companies to those starting to scale, offering initial investments ranging from $400K to $4M​.

Nina Capital is a specialized venture capital firm based in Barcelona, focusing on early-stage investments in health technology. Founded by Marta Gaia Zanchi, the firm invests across Europe, the United States, Canada, Israel, and Australia. Nina Capital leverages the Biodesign process from Stanford, which emphasizes a need-driven and value-based approach to healthcare innovation. Their investment strategy spans pre-seed to seed stages, with typical investment sizes ranging from €200k to €1.5m​. The firm supports startups that apply advanced data science, engineering innovation, and IT-enabled products to solve healthcare challenges. Notable portfolio companies include QuantHealth, which uses AI to predict patient responses in clinical trials, and Cardiomatics, offering automated ECG interpretation to improve healthcare efficiency​. The core team, led by principals like Anastassiou and Yahel Halamish, combines deep expertise in healthcare, technology, and investment. They are committed to diversity and multidisciplinary collaboration, fostering an inclusive environment that promotes innovative solutions to complex healthcare problems.

North Bridge Venture Partners, founded in 1994 and based in Wellesley, Massachusetts, is a venture capital firm that provides seed-to-growth financing. The firm focuses on several key sectors, including communications and infrastructure, software, materials, healthcare, and digital media. North Bridge Venture Partners supports companies from their initial stages through to becoming market leaders, leveraging a combination of operational experience and strategic guidance​. The firm has made over 479 investments and has achieved 183 exits. Notable portfolio companies include Couchbase, Markforged, and Lyra Therapeutics. North Bridge has a significant presence in the U.S. market, focusing primarily on early-stage and growth-stage companies operating in healthcare and information technology sectors​. North Bridge is led by a team of experienced professionals, including founder and managing partner Edward Anderson and general partners Richard D'Amore and Jeffrey McCarthy. The firm's strategy emphasizes investing in exceptional entrepreneurs whose ideas have the potential to disrupt their respective industries.

New Venture Fund (Norwest Venture Partners) is a leading venture capital and growth equity investment firm with a diversified investment strategy. It focuses on early- to late-stage investments across various sectors, including consumer, enterprise, and healthcare. Norwest has a robust global presence with offices in North America, India, and Israel, enabling it to identify and support innovative companies worldwide. Notable investments by Norwest include companies like Dave, Gong, Swiggy, Udemy, Vuori, and Ritual. These investments demonstrate the firm's commitment to backing visionary leaders and transformative businesses. Norwest’s investment strategy includes providing not only capital but also strategic guidance and operational support to help portfolio companies scale and achieve significant growth. The firm has recently launched its $3 billion fund, NVP XVI, to continue empowering high-impact businesses. In recent years, Norwest has expanded its focus within the healthcare sector to include biotechnology, building on its successes in medical devices, diagnostics, and healthcare services. Norwest's notable exits include companies such as Opendoor, Talkspace, Udemy, Aporeto, CyberX, and Shape Security, among others. The firm is also committed to environmental, social, and governance (ESG) principles, investing in companies that prioritize sustainability and social impact​.

Novo Holdings is a premier life sciences investment firm based in Copenhagen, Denmark, with additional offices in Boston, San Francisco, London, and Singapore. The firm is wholly owned by the Novo Nordisk Foundation and manages an extensive portfolio aimed at generating long-term returns while advancing health and sustainability. Novo Holdings focuses on investments across biotechnology, medical technology, and digital health sectors, supporting companies at various stages, from early development to commercial phases. In 2023, the firm deployed DKK 3.6 billion, including significant investments in 4D Molecular, Alentis Therapeutics, and Lexeo Therapeutics. The firm's strategy emphasizes innovation in patient care and strong financial returns. Notably, Novo Holdings operates with an evergreen fund structure, allowing a long-term perspective on its investments. The firm actively engages with portfolio companies, often taking board positions to leverage its vast network and expertise. The investment team, led by Managing Partner Scott Beardsley, comprises professionals across major life science hubs. Key team members include Amit Kakar, Head of Novo Holdings Asia, and Anna Fan, Senior Partner in the Life Sciences Operating Committee. For startups seeking investment, Novo Holdings values groundbreaking science and robust clinical data, favoring companies with late preclinical or clinical stage compounds in biotech, and commercial stage entities in medtech and digital health

Nutreco is a global leader in animal nutrition and aquafeed, committed to sustainably feeding the growing global population. Headquartered in the Netherlands, Nutreco operates through two primary business lines: Skretting, which focuses on aquaculture, and Trouw Nutrition, which serves the livestock industry. The company’s overarching mission, known as "Feeding the Future," is to drive sustainability across the entire food production chain. Nutreco's strategy is centered around three main areas: supporting sustainable production through technology, advancing nutrition and animal health, and sourcing future protein ingredients. The company is heavily invested in developing sustainable alternatives to traditional feed ingredients, including the use of insect protein and other novel sources. This approach aims to reduce the environmental footprint of animal farming, which is crucial as feed ingredient production currently accounts for a significant portion of greenhouse gas emissions in the livestock industry. Innovation is a key pillar of Nutreco's operations, primarily driven by their NuFrontiers team, which focuses on breakthrough technologies that can transform the protein value chain. Nutreco has also been expanding its production capabilities in growth markets like Asia and Latin America, as well as optimizing its operations to increase agility and reduce costs. The company’s investments are aimed at not just expanding its market presence but also ensuring that its products and practices are aligned with global sustainability goals, making it a crucial player in the future of food production​.

OCA Ventures, based in Chicago, is an early-stage venture capital firm that has been investing since 1999. The firm primarily targets technology, financial services, education, and healthcare technology sectors. Their investment strategy focuses on Seed, Series A, and Series B rounds, with typical initial investments ranging from $1 to $4 million. They often lead the rounds in which they participate. Notable companies in their portfolio include SpotHero, a parking app; Base CRM, a cloud-based customer relationship management software; Pangea, an online money transfer service; and Cleversafe, a cloud-based data storage system. Other significant investments include dv01, LogicGate, and Placer.ai. OCA Ventures is also known for its OCA EDGE program, which invests $50,000 to $200,000 in seed rounds of about $1.5 million or less. This program is designed to support early-stage startups with potential for dramatic growth. The firm has a strong track record of successful exits, including the sale of Cleversafe to IBM and the IPO of Marqeta. Led by CEO Jim Dugan and co-founders John Dugan and Peter Ianello, OCA Ventures leverages a robust network of strategic relationships to support their portfolio companies and drive their growth.

Ocean 14 Capital is a private equity firm dedicated to transforming the "blue economy," with a strong focus on addressing environmental challenges while generating competitive financial returns. Established in 2020, the firm primarily invests in sectors like sustainable aquaculture, alternative proteins, circular plastics, and ocean conservation technologies. Its mission aligns with the United Nations’ Sustainable Development Goal 14 (SDG 14), which aims to conserve and sustainably use ocean resources​. The firm has successfully raised €200 million for its first fund, attracting cornerstone investors such as the European Investment Fund (EIF), Minderoo Foundation, and Chr. Augustinus Fabrikker. Ocean 14’s investment strategy targets companies with innovations that protect marine ecosystems and promote food security, such as SyAqua (shrimp genetics and nutrition) and AION (a circular plastics service)​. Ocean 14 seeks to drive sustainable growth in the blue economy, a sector expected to reach $3 trillion by 2030. They aim to invest in 20-25 companies, with an emphasis on scalable technologies that offer both environmental impact and financial returns​.

OCV Partners is a Los Angeles-based venture capital firm, established with a mission to invest in companies that demonstrate significant growth potential, primarily in the technology and healthcare sectors. Their investment strategy is focused on mid- to late-stage companies, often in fields such as SaaS, fintech, biotech, and digital health. With a portfolio that includes innovative firms like Jukin Media, Scopely, and TaskUs, OCV Partners has positioned itself as a hands-on investor, providing both capital and operational support to help scale high-growth companies​. The firm prides itself on its diverse expertise, backing founders through every phase of their business journey. The OCV team brings decades of experience in building and scaling companies across various industries, from software and financial services to healthcare and media. They partner with startups not just to provide financial backing, but also to offer operational insight, helping businesses navigate the complexities of scaling. OCV Partners is well-known for its long-term mindset, focusing on building sustainable value through innovation and strong partnerships. The firm typically invests in companies at the seed to Series B stages, though they remain flexible and open to later-stage opportunities when appropriate.

Odey Asset Management, once a prominent name in the investment industry, is currently undergoing significant changes as it winds down its operations. Founded by Crispin Odey in 1991, the firm became known for its high-conviction, often contrarian investment strategies, and managed substantial assets across various funds. However, recent developments have led to the closure of the firm, including its subsidiaries such as Brook Asset Management and Odey Wealth. As part of the wind-down process, Odey Asset Management is in the midst of transferring its fund management responsibilities to new asset managers. This transition aims to ensure continuity for investors, allowing for a smoother handover of the funds under its management. The firm is working closely with regulatory authorities to manage this transition in a way that protects the interests of its clients. For investors and clients, the firm’s website provides the most up-to-date information regarding the ongoing closure and transfer of assets. Detailed statements and guidance are available to help investors navigate this period of change, offering insights into how their investments will be managed moving forward. The closure marks the end of an era for Odey Asset Management, which had been a significant player in the global investment landscape for over three decades. Despite its current challenges, the firm’s legacy in shaping high-risk, high-reward investment strategies remains noteworthy.

Ombu Group is a London-based venture capital firm that specializes in investing in advanced environmental and industrial technologies. Established in 2011, Ombu Group focuses on high-impact sectors such as energy optimization, EV charging infrastructure, and sustainable technologies. The firm typically invests in Series A and B stages, with investments ranging from €1.5 million to €3 million. Ombu Group's investment approach combines strategic capital with deep industry knowledge and operational support, aiming to help businesses scale sustainably and achieve market leadership. The firm has a concentrated portfolio and partners closely with visionary entrepreneurs to drive innovation and transformative growth. Some of their notable investments include companies like Iceotope, Bowman Power, and Driivz. The leadership team at Ombu Group includes Stephen Brooke as the founder and CEO, supported by a small but experienced team that brings a wealth of expertise in technology and finance. Their focus on sustainability and long-term growth has positioned Ombu Group as a key player in advancing technology for a greener future.

OMERS Ventures, the venture capital arm of the Ontario Municipal Employees' Retirement System, focuses on investing in Series A to C companies across North America. Founded in 2011, the firm has backed several high-profile tech companies like Shopify and Wave. Their investment strategy centers on transformative technology sectors, including fintech, healthtech, proptech, and workplace technology. Typical initial investments range from $5 million to $25 million. OMERS Ventures has decided to withdraw from the European market to concentrate its efforts on North America. This strategic shift follows a challenging market environment in Europe and aims to leverage North America's relative economic stability. As part of this transition, the firm plans to open a new office in New York while maintaining its presence in Toronto and San Francisco. The leadership team includes Michael Yang, who emphasizes the importance of building strong relationships with founders and has a background in investing in emerging areas such as healthtech and IoT. For startups looking to engage with OMERS Ventures, demonstrating a deep understanding of the market and a clear vision for growth is essential. The firm values transparency and strong founder-investor relationships, aiming to support companies through various market challenges and opportunities.

One Way Ventures, founded in 2017 and headquartered in Boston, Massachusetts, is a venture capital firm dedicated to investing in immigrant founders. The firm focuses on seed-stage and early-stage companies across various sectors, including logistics, mobility, fintech, proptech, deep tech, consumer technology, healthcare, AI, machine learning, and robotics. Notable investments by One Way Ventures include Brex, Chipper Cash, Classtag, and Momentus. The firm has made significant exits, such as Legalpad, acquired in 2022, and Lynk, a satellite communications company​. The portfolio is diverse, featuring companies like Beacon, an AI-powered workflow automation platform for logistics; Brelyon, a deep tech company creating virtual screens; and Care Academy, a caregiver training platform. Co-founded by Semyon Dukach and Eveline Buchatskiy, One Way Ventures aims to support high-impact global companies driven by the unique perspectives and experiences of immigrant founders. The firm values equal opportunity and the collective potential of humankind, striving to eliminate borders as barriers to innovation and growth​.

Opera Tech Ventures is a Paris-based venture capital firm launched in 2018 as the investment arm of BNP Paribas. Specializing in fintech, insurtech, AI, sustainability tech, and enterprise software, Opera Tech Ventures targets startups with cutting-edge solutions in these sectors. They predominantly invest in Series A to D rounds, with a focus on scalable technologies that address critical market needs. The firm typically invests between $3 million and $15 million per deal, often taking a leadership role in the funding process. Their portfolio includes companies like SESAMm, an AI-driven analytics firm, Stoik in cloud security, and Arbol in commercial insurance. With a global scope, Opera Tech Ventures invests across Europe and North America, particularly favoring markets in France, the UK, the US, and the Netherlands. Their investment strategy is driven by a deep understanding of fintech and enterprise solutions, looking for startups that can revolutionize industries and show strong growth potential. Co-investing with well-known partners like Andreessen Horowitz and Munich Re Ventures, Opera Tech Ventures ensures their portfolio companies receive both capital and strategic guidance​. Under the leadership of Thibaut Schlaeppi, the firm is highly engaged in supporting portfolio companies beyond just financial backing. They offer insights, mentorship, and extensive connections across industries. Their diverse team brings expertise from multiple sectors, allowing them to help companies scale effectively in highly competitive markets. By focusing on innovation, Opera Tech Ventures continues to build a robust portfolio of future-leading companies.

Optum Ventures is a prominent venture capital firm focused on transforming healthcare through strategic investments in innovative digital health startups. Notable portfolio companies include Buoy Health, which uses AI to guide patients in understanding symptoms, and Mindstrong Health, which leverages AI to diagnose and treat neuropsychiatric disorders through smartphone interactions. Other significant investments include Dispatch Health, which provides in-home medical care, and Equip, specializing in virtual eating disorder treatments. Optum Ventures primarily invests in early to growth-stage companies that utilize data-driven technologies to improve healthcare delivery, access, and payment systems. Their geographic focus spans the United States and international markets, reflecting a commitment to global healthcare innovation. The fund's strategy emphasizes partnering with startups to provide not just capital, but also access to Optum's extensive healthcare expertise and market presence. They typically lead investment rounds and are highly involved in guiding the strategic direction of their portfolio companies. Key team members include Larry Renfro, Managing Partner, who brings extensive experience from UnitedHealth Group, and Vijay Barathan, who focuses on digital health investments. The team is based across major hubs in the US and Europe, ensuring a diverse and comprehensive approach to investment and support.

Origin Ventures is an early-stage venture capital firm based in Chicago, Illinois, founded in 1999 by Steve Miller and Bruce Barron. The firm focuses on investing in high-growth software, marketplace, and consumer businesses that are shaping the Digital Native Economy. Origin Ventures has a strong track record, having raised over $300 million across multiple funds and achieving notable exits with companies like Grubhub, Cameo, Fountain, and Tock​. The firm recently closed its fifth fund at $130 million, exceeding their initial target despite the challenges posed by the COVID-19 pandemic. This new fund continues to emphasize investments in the Digital Native Economy, targeting themes such as the workplace of the future, the creator economy, and the circular economy. Recent investments from this fund include companies like Blueboard, Vivrelle, Veho, Lumanu, and Everee. Origin Ventures operates with a thesis-driven approach and maintains a presence in all four continental U.S. time zones, with offices in Chicago, Salt Lake City, San Francisco, and Washington, D.C. This geographic diversity allows them to be close to elite teams and investment opportunities across North America​. The firm prides itself on its hands-on partnership with founders, offering extensive support from their experienced team of former entrepreneurs, operators, and engineers. This commitment has helped them build a portfolio of companies that have consistently delivered strong returns and defined new market categories.

Origins Fund is a unique venture capital firm that specializes in backing consumer technology startups from pre-seed to Series A. What sets Origins apart is its strategy of combining financial investment with the power of social influence. The fund's limited partners include high-profile athletes and celebrities who collectively have over 160 million social media followers. This provides an "unfair advantage" to the startups in its portfolio by significantly boosting their visibility and growth potential. Origins typically invests between $100,000 and $500,000 per startup and reserves additional capital for follow-on investments in the most promising companies. The fund focuses on category-defining consumer businesses, particularly those that can benefit from the massive influence and reach of its celebrity LPs. The fund's co-founders, including former French football star Blaise Matuidi, are based in global hubs like Miami, New York, and Paris, allowing Origins to maintain a diverse and internationally connected portfolio. Notable investments include companies like Upway, a marketplace for reconditioned e-bikes, and Moka.care, a corporate mental health solution.

OurCrowd, founded in 2013 and headquartered in Jerusalem, is a leading global venture capital platform. It offers accredited investors access to pre-vetted startups, exclusive venture funds, and alternative investments. The firm’s portfolio covers sectors such as healthcare, AI, robotics, energy, and fintech, with notable investments in Beyond Meat, JumpCloud, and Lemonade. Beyond Meat, a leader in plant-based foods, and Lemonade, an AI-driven insurance company, both had successful IPOs and continue to thrive. OurCrowd’s investment strategy involves thorough due diligence and active support for portfolio companies, ranging from seed to growth stages. They typically invest between $1 million and $5 million, offering strategic guidance and access to a global network of co-investors and operational support​. The firm operates globally, with a strong presence in Israel and the U.S., and investments in Europe, Asia, and Latin America. This global reach allows them to tap into diverse markets and innovative ecosystems. Led by CEO Jon Medved, OurCrowd’s team includes investment professionals across multiple offices worldwide, ensuring a comprehensive approach to emerging technologies and market opportunities. Startups seeking investment should highlight their innovation, scalability, and market potential, approaching OurCrowd through their network or platform to increase funding chances

Outsiders Fund, founded in 2020 and based in New York, focuses on early-stage investments in disruptive technologies. The fund backs founders challenging traditional industries with innovative solutions. Outsiders Fund has a diverse portfolio across various sectors, including enterprise software, healthcare, cybersecurity, and aerospace. Notable investments include RaySecur, which provides mail and package security solutions using mmWave imaging technology; Casana, which offers remote patient monitoring via a smart toilet seat; and Dyania Health, which matches patients for clinical trials. Another significant investment is in Apex, a company focused on spacecraft manufacturing​. The fund typically invests in seed and early-stage rounds, with an average round size of $11M. Recent investments include Gradial, a generative AI content creation platform, and PaintJet, a robotics company specializing in painting commercial spaces. Led by Managing Partner Theodore Seem and supported by a team of experienced professionals, Outsiders Fund aims to partner with founders to drive growth and innovation in their respective fields. Their approach involves close collaboration with portfolio companies, providing strategic guidance and facilitating key industry connections.

Overton Venture Capital, based in New York, is a woman-led early-stage VC firm with a sharp focus on investing in seed and early-stage companies that are driving transformative changes in technology and consumer behavior. The fund is particularly interested in sectors like digital health, fintech, edtech, and consumer products. Some of their notable investments include K Health, Stash, and Bringg, which highlight their commitment to backing companies with strong technological underpinnings poised for significant market disruption. The fund’s investment strategy revolves around identifying and supporting diverse founding teams that not only demonstrate innovative product vision but also exhibit fiscal discipline and rapid growth potential. Overton VC is known for its hands-on approach, leveraging the deep operational expertise of its partners to actively support portfolio companies in scaling their businesses. The team is led by co-founders Kerry Miller and Michael Nogen, both seasoned professionals with extensive experience in management consulting, corporate strategy, and entrepreneurship. They emphasize a collaborative, transparent partnership with founders, aiming to build businesses with sustainable, long-term value. Startups seeking investment are encouraged to have a clear path to revenue and a strong, integrity-driven leadership team.

Pallasite Ventures is a venture capital firm that focuses on providing early-stage financing to high-growth companies across a variety of industries, including tech and consumer products. Founded in 2012 and based in Vancouver, Canada, Pallasite Ventures aims to fund companies whose leaders have the vision and skill to transform their markets. The firm is particularly active in Seed and Series A deals, offering investments ranging from $100,000 to $1.5 million USD and maintaining significant reserves to support their portfolio companies as they grow. The firm has invested in over 60 companies, including notable names like Dooly, Prescryptive, and CalypsoAI. Pallasite Ventures places a strong emphasis on adding value and providing support to its portfolio companies, ensuring they have the resources and freedom needed for long-term growth. The firm's investment focus spans multiple regions, including Vancouver, San Francisco, Boston, Denver, Chicago, and Toronto. Pallasite Ventures is led by Managing Partner Christopher Bissonnette, Ph.D., and operates with an agile and supportive approach, aiming to streamline decisions and provide strategic advice to its investments​.

Palm Drive Capital, headquartered in New York City with additional offices in San Francisco and Taipei, is a venture capital firm that specializes in early-stage investments. Founded in 2014, the firm primarily backs Seed and Series A tech founders across SaaS, AI, fintech, and e-commerce sectors. Their global approach underscores their belief that "innovators are everywhere," supporting startups from diverse geographical regions​. The firm has a notable portfolio, including investments in Deep Instinct, a leader in cybersecurity, and MoneyLion, a modern challenger bank. Palm Drive Capital has also achieved significant exits, such as those from Clover Health and Long Game, highlighting their success in identifying and nurturing high-potential startups​. Palm Drive Capital prefers a collaborative investment approach, frequently co-investing with other venture firms rather than leading rounds. Their strategy focuses on scalable solutions in high-growth markets, providing not only financial support but also strategic guidance through their extensive network. This approach has positioned them as a valuable partner for early-stage companies looking to scale efficiently. Led by co-founders Hendrick Lee and Seamon Chan, the team comprises experts like Catherine Cai and Nick Hsu, who contribute significant investment and operational expertise. For startups aiming to engage with Palm Drive Capital, demonstrating a robust product-market fit and a clear scalability plan is crucial. The firm values well-prepared pitches that highlight market opportunities and strategic growth plans​.

Panache Ventures is a leading Canadian venture capital firm specializing in early-stage investments, particularly at the pre-seed and seed stages. Founded in 2018, the firm has a strong national presence with offices in Vancouver, Calgary, Toronto, and Montreal. Panache Ventures focuses on supporting ambitious entrepreneurs across various sectors, including enterprise software, AI/ML, fintech, blockchain/web3, health tech, and climate tech. Panache Ventures' first fund raised over $58 million and invested in 100 companies, achieving notable exits such as fintech company Flinks and proptech company Lane. Their second fund, Panache Ventures II, closed at $100 million, with significant investments from Alberta Enterprise Corporation, Ontario Capital Growth Corporation, Investissement Québec, BMO Financial Group, and TELUS Ventures. This fund aims to double down on pre-seed and seed investments in Canadian technology startups, supporting around 20 new investments per year​. The firm is known for its commitment to diversity and inclusion, with 52% of its portfolio companies being led by persons of color and a rate of investment in women-led startups that is 1.8 times the national average for Canadian venture capital​​. Panache Ventures emphasizes a founder-friendly approach, providing extensive mentorship and support throughout the growth of their portfolio companies. Key team members include Chris Neumann, Scott Loong, Prashant Matta, and Patrick Lor, who collectively bring a wealth of experience and expertise to the firm.

Pangaea Ventures is a leading venture capital firm specializing in hard tech and impact investments. Focused on leveraging advancements in materials science, chemistry, and biology, Pangaea Ventures invests in startups addressing global challenges like climate change, food security, and human health. Their portfolio includes innovative companies such as CarbonCure, Aspect Biosystems, and NewLeaf Symbiotics, which are pioneering solutions in carbon sequestration, bioprinted tissues, and sustainable agriculture, respectively. With a geographic focus on North America, Pangaea Ventures typically invests in early to growth-stage companies. Their investment strategy centers around creating measurable impact, often leading investment rounds with significant capital. They are particularly interested in startups that can demonstrate clear, scalable solutions to critical environmental and health problems. Pangaea Ventures' team, based in Vancouver, Scottsdale, and Hillsborough, includes experts like General Partner Chris Erickson, who bring extensive experience in science and business. The firm is known for its rigorous due diligence process and close collaboration with portfolio companies to maximize both financial and impact returns. Startups are encouraged to approach Pangaea with detailed proposals that highlight innovative, market-ready technologies. In summary, Pangaea Ventures is a key player in the venture capital landscape, driving sustainable innovation through strategic investments in transformative technologies.

Pantera Capital is a pioneering venture capital firm focused exclusively on blockchain and cryptocurrency investments. Founded by Dan Morehead in 2003, Pantera launched the first cryptocurrency fund in the U.S. in 2013 when Bitcoin was valued at $65 per BTC. They have since introduced various funds, including the first blockchain-focused venture fund and the first early-stage token fund in 2017. Pantera manages $5.6 billion in assets, providing investors with comprehensive exposure to the blockchain ecosystem through venture equity, early-stage tokens, and liquid tokens. Their investment strategy is global, having backed over 100 blockchain companies and 110 early-stage token deals across sectors like decentralized finance (DeFi), next-gen payment systems, and institutional trading tools. The firm's notable funds include the Pantera Venture Funds, Pantera Bitcoin Fund, Pantera Liquid Token Fund, and the all-encompassing Pantera Blockchain Fund. Their extensive portfolio features key players in the blockchain space, contributing significantly to the industry's infrastructure and growth. Pantera Capital operates from offices in the Bay Area, New York, and Puerto Rico, with a team of seasoned professionals bringing decades of experience from top-tier financial firms and technical backgrounds.

Pappas Capital is a prominent venture capital firm based in Durham, North Carolina, specializing in investing in next-generation life science, agriculture, and technology companies. Established in 1994 by Art Pappas, the firm has a robust track record of investing in over 90 companies across the United States, Canada, and Asia. Their investments focus on innovative solutions that address significant unmet medical needs and span a wide range of diseases, including cancer and hemophilia​. Pappas Capital operates through three primary divisions: Pappas Ventures, Specialized Fund Management, and Translational Medicine. Pappas Ventures is their flagship arm, dedicated to life science investments, particularly in undercapitalized markets. Specialized Fund Management creates and manages custom investment vehicles, while Translational Medicine partners with academic institutions to accelerate the development of scientific discoveries. The firm boasts a seasoned team of investment professionals, including Art Pappas, Elizabeth Kelly, and Barry Myers, who bring extensive experience in pharmaceuticals, biotechnology, and venture capital. This expertise enables Pappas Capital to provide valuable insights and strategic guidance to their portfolio companies, helping them navigate the complexities of drug development and commercialization. Pappas Capital has successfully guided numerous companies to significant exits, including IPOs and acquisitions. Recent investments include companies like VFlow Tech and Enlaza Therapeutics, further emphasizing their commitment to advancing groundbreaking life science technologies​.

Paradigm Ventures is a prominent venture capital firm that excels in investing within the cryptocurrency and blockchain technology sectors. Their portfolio boasts notable investments such as Coinbase, Chainalysis, and OpenSea, reflecting their strong presence in the digital assets space. They focus on investing in early-stage ventures but also support companies through various growth stages with investment sizes ranging from $1M to $100M. Paradigm's investment strategy is deeply research-driven, often leading rounds and providing significant hands-on support in areas like technical mechanism design, smart contract security, and operational scaling. This approach not only ensures the technological robustness of their portfolio companies but also aids in achieving long-term growth and market leadership. Geographically, Paradigm is heavily invested in the United States, particularly within major tech hubs such as San Francisco. However, their investments and interest span globally, targeting innovative companies that push the boundaries of blockchain technology. Paradigm prefers to be approached by startups with a clear and compelling vision for their technology and its impact on the crypto ecosystem. They are highly selective, looking for teams with strong technical foundations and a demonstrated ability to execute their vision effectively.

Philips Ventures is the venture capital arm of Royal Philips, focusing on early- to growth-stage investments in healthcare technology startups that align with Philips’ mission to improve patient outcomes, reduce healthcare costs, and transform the healthcare experience. Established in 1998 and based in Amsterdam, Philips Ventures invests globally, supporting companies that develop digital health solutions, medical devices, and health technology services. The fund is business-agnostic but emphasizes sectors like digital software, AI-driven health solutions, and technology-enabled services. Philips Ventures provides not just capital but also strategic support, offering startups access to Philips' extensive clinical and regulatory expertise, global market insights, and deep relationships within the healthcare industry. Their investment strategy includes leading or co-leading rounds, with initial investments typically ranging from $2 million to $5 million, and they actively syndicate deals to collaborate with other investors. Philips Ventures also fosters partnerships between their portfolio companies and Philips' various business units, helping startups scale and navigate the complex healthcare landscape. This approach has led to investments in companies like Elucid, Validic, and MIVI Neuroscience, all of which are pushing the boundaries of healthcare innovation.

Phoenix Venture Partners (PVP), established in 2010 and headquartered in San Mateo, California, is a venture capital firm that specializes in investing in early-stage startups with breakthrough materials science innovations. The firm focuses on sectors such as advanced materials, photonics, electronics, and clean technology. Their investment strategy encompasses seed, venture, and growth stages, providing both capital and strategic guidance to drive the commercialization and scalability of innovative technologies​. PVP has a robust portfolio, including companies like Inkbit, which develops advanced additive manufacturing systems, and FIGUR8, which creates wearable musculoskeletal technology. Other notable investments include Agrology, a company in the agriculture biotechnology space, and Ubicept, specializing in computer vision and image recognition​. The firm is led by experienced professionals such as Dr. Frank Levinson, a co-founder and Managing General Partner, who has a strong track record in building advanced materials companies and was the founder of Finisar Corporation. PVP's recent investments highlight their commitment to transformative technologies, with a focus on sectors that have substantial growth potential and societal impact.

Pirveli Ventures is a Montreal-based family fund that focuses on early-stage investments, particularly in Israeli startups. The fund is known for its laid-back, hands-on approach, providing both initial and follow-on investments while actively supporting portfolio companies in areas like strategy, business development, and management. This close involvement allows Pirveli to act as an extension of the startup teams they back. Their investments typically center around sectors such as agricultural tech, health tech, sustainability, and automotive technologies. Notable companies in their portfolio include Gordian Surgical, Eco Wave Power, and Flora Fotonica, reflecting a commitment to innovative, high-impact ventures. Pirveli Ventures generally invests in the seed stage, and while they do not limit themselves to a specific check size, they are comfortable co-investing alongside other funds. Their investment philosophy focuses on working with startups that have a clear business plan and strong management teams, helping them transition from innovative ideas to successful companies​.

Planeteer Capital is a venture capital firm based in New York City that focuses on pre-seed and seed-stage investments in climate tech startups. Founded by Sophie Purdom, a co-founder of Climate Tech VC (CTVC), Planeteer Capital aims to partner with founders who are addressing the challenges of climate change through innovative technologies and solutions. The firm is anchored by an Ivy League endowment and backed by notable investors including Collaborative Fund and former Meta CTO Mike Schroepfer. Planeteer Capital targets sectors such as carbon management, industrial decarbonization, the built environment, climate intelligence and insurance, and sustainable agriculture. The firm’s mission is to empower visionary founders with the necessary capital and network to prove and scale their transformative models. Planeteer Capital distinguishes itself by providing not just financial support, but also strategic guidance and a sophisticated understanding of the climate tech capital stack​​.

Plug and Play Tech Center, headquartered in Sunnyvale, California, is the world’s largest startup accelerator and a leading venture capital firm. Known for its expansive global reach, Plug and Play operates in over 50 locations across five continents. Their notable investments include industry giants like PayPal, Dropbox, and LendingClub, along with a portfolio boasting more than 30 unicorns such as Honey and Guardant Health. Focusing on diverse industries such as fintech, health, insurtech, and supply chain, Plug and Play leverages its robust corporate network of 450 partners to drive innovation. Their investment strategy is characterized by small, pre-seed and seed-stage checks typically ranging from $100,000 to $150,000. They maintain an active presence globally, investing equally in U.S.-based and international startups. The firm's founder and CEO, Saeed Amidi, emphasizes high energy and a global approach to foster entrepreneurship. Key team members like George Damouny play vital roles in maintaining Plug and Play’s status as one of the most active investors worldwide. Plug and Play’s investment approach is unique, often engaging startups through their acceleration programs without necessarily investing in every participant. They focus on building ecosystems around each industry to maximize startup potential. Recently, the firm has made 102 investments in Q1 2023 alone, underscoring its dynamic and proactive investment strategy.

Polaris Partners, a venture capital firm established in 1996 and headquartered in Boston, Massachusetts, has a distinguished history of investing in transformative healthcare and biotechnology companies. With over 400 companies funded, more than 100 exits, and 50 IPOs, Polaris Partners has solidified its position as a leading investor in the industry​​. The firm's portfolio is diverse, including notable companies such as Ironwood Pharmaceuticals, JibJab Media, LegalZoom, and Living Proof. Polaris Partners focuses primarily on healthcare, life sciences, and biotechnology sectors, targeting innovative care delivery models, digital health solutions, patient and provider platforms, and data science and analytics​ ​. Polaris Partners operates multiple funds, including the Polaris Growth Fund, which supports the expansion of profitable, founder-owned technology companies, and the Polaris Innovation Fund, aimed at accelerating the commercial and therapeutic potential of early-stage academic research​​. Key team members include Brian Chee, Bryce Youngren, and Alexandra Cantley, who bring extensive expertise and leadership to the firm's investment strategies. Polaris Partners prides itself on being more than just investors—they are builders and connectors with a deep network of syndicate partners, universities, and research institutions​​. For entrepreneurs, Polaris Partners offers robust support, leveraging their decades of experience and comprehensive network to help companies achieve successful outcomes and bring innovative therapies to market.

Pontifax Venture Capital is a healthcare-focused venture capital firm based in Herzliya, Israel, founded in 2004. The firm manages approximately $1.2 billion across multiple funds and focuses on identifying and investing in transformative life sciences technologies at all stages of development. Pontifax's portfolio includes around 100 companies that address significant unmet medical needs through groundbreaking innovations​. The firm was co-founded by Eli Hurvitz, a legendary figure in the pharmaceutical industry and former CEO of Teva Pharmaceuticals, alongside Ran Nussbaum and Tomer Kariv. Pontifax takes a hands-on approach with its portfolio companies, providing strategic guidance and leveraging extensive networks to help these companies grow and succeed. Pontifax's investment strategy spans various sectors within the life sciences, including biopharmaceuticals, medical devices, and gene therapy. Notable investments include Kite Pharma, which was acquired by Gilead Sciences, and Eloxx Pharmaceuticals, which focuses on treatments for genetic diseases caused by nonsense mutations.

Pool Global Partners is a venture capital firm that focuses on investing in high-growth technology companies, with an emphasis on sectors such as healthcare, software development, and biotechnology. Founded in 2016 and based in Toronto, Pool Global Partners aims to back innovative startups that leverage deep technology to create transformative solutions. The firm operates with an outcome-driven approach, providing both financial capital and strategic support to help startups scale efficiently. Pool Global Partners’ portfolio includes investments in companies like modl.ai, an AI gaming startup, Prescryptive Health, a healthcare technology company, and Acorn Biolabs, a biotechnology firm. The firm’s investment strategy is centered around early-stage ventures, particularly in seed and Series A rounds, with an average deal size of around $1 million. With a global presence, Pool Global Partners actively collaborates with other venture firms such as Saltagen Ventures and PreSeed Ventures, co-investing in high-potential startups across North America and Europe. Their goal is to support technological innovation that addresses critical challenges, particularly in sectors that are poised for significant growth.

Portage Ventures is a leading venture capital firm specializing in fintech and financial services, with a strong presence across North America and Europe. They have invested in notable companies like Wealthsimple, KOHO, and Albert, reflecting their keen focus on innovative financial technology solutions. Portage's investment strategy is thesis-driven and covers seed to Series C stages, targeting sectors such as consumer finance, insurance, wealth management, and fintech infrastructure. Their geographic focus spans the United States, Canada, Europe, Australia, and Israel, with major offices in Montreal, Toronto, New York, San Francisco, and Paris. Portage Ventures prides itself on a deep, hands-on approach, providing not just capital but also strategic support through their Value Creation team, which includes experts in go-to-market strategies, technology, cybersecurity, and business acceleration. Led by seasoned professionals like Paul Desmarais III and Adam Felesky, the firm is committed to long-term partnerships and aims to empower entrepreneurs to reshape financial services. They are particularly interested in transformative fintech ideas that promote financial transparency, efficiency, and inclusion. Portage Ventures stands out for its rigorous, collaborative, and innovative culture, which is part of the broader Sagard ecosystem, managing over $3.3B in assets across various investment strategies. This extensive network offers portfolio companies unparalleled access to industry experts, strategic partners, and growth opportunities​.

Precursor Ventures is a San Francisco-based venture capital firm founded in 2015 by Charles Hudson. The firm specializes in pre-seed and seed investments, focusing on long-term relationships with founders. Precursor Ventures invests primarily in B2B and B2C software applications and hardware across the United States, Canada, and Mexico​​. Some notable investments from Precursor Ventures include The Athletic, Betty Labs, and Intellimize. The firm has a diverse portfolio, backing over 300 companies and achieving significant exits, such as Ele.me (acquired by Alibaba) and Qunar (NASDAQ: QUNR). Their investment approach emphasizes supporting underrepresented founders and pioneering ideas in untapped markets​. The team at Precursor Ventures, led by Charles Hudson, includes experienced professionals like Marina Girgis and Ashtan Jordan. They bring a wealth of knowledge from various industries, including technology and finance. The firm's strategy revolves around providing substantial support to startups from the earliest stages of their development, helping them scale and grow​​. For startups seeking investment, Precursor Ventures values clear, compelling pitches that align with their focus on innovation and potential market impact. They prefer to build strong, supportive relationships with founders to ensure long-term success​

Presight Capital, founded in 2019 by Christian Angermayer in partnership with Apeiron Investment Group, is a global venture capital firm based in West Hollywood, California. The firm manages over $600 million in assets across two early-stage funds and focuses on investing in biotechnology, consumer, fintech, deep tech, food tech, cryptocurrency, healthcare, and technology sectors. Notable investments by Presight Capital include ATAI Life Sciences, a mental health company using psychedelics; AbCellera, a biotech firm specializing in antibody therapies; and Compass Pathways, which focuses on mental health treatments using psilocybin. Other prominent companies in their portfolio are General Fusion, EnergyVault, and Perfect Day, which produces lab-grown dairy products. Presight Capital aims to support ambitious founders by providing capital, connections, and strategic advice. They invest in various stages, from seed to IPO, and have a diverse portfolio that includes companies like Razor Group, Syfe, and Alto Neuroscience. The firm's approach is characterized by a strong emphasis on transformative technologies and groundbreaking solutions across different industries​.

Princeville Capital is a global venture capital firm founded with a focus on investing in growth-stage technology companies. The firm has offices in key global hubs, including San Francisco, Berlin, and Hong Kong. Princeville Capital operates two main funds: Princeville Global, which invests in technology market leaders, and Princeville Climate Tech, which focuses on companies that leverage technology to address climate change challenges. Princeville Capital targets sectors such as enterprise SaaS, AI, fintech, digital health, e-commerce, and blockchain/web3. The firm's investment strategy emphasizes backing companies that are not only leaders in their fields but also have proven business models and are positioned for rapid growth. Princeville’s global reach allows them to apply best practices from various markets and support companies in expanding their operations internationally. The firm’s leadership team includes experienced professionals like Emmanuel DeSousa and Joaquin Rodriguez Torres, who bring a wealth of knowledge in capital markets and strategic growth. They provide strategic counsel and help portfolio companies with follow-on capital raises and IPO preparations, ensuring that they are well-positioned for long-term success.

Pritzker Group, founded by the Pritzker family, is a diversified investment firm with a robust portfolio spanning private capital, venture capital, and asset management. Their investment strategies leverage a permanent capital base, allowing for flexible, long-term investments without the constraints of traditional funding timelines. This approach benefits from the Pritzkers' extensive network, which includes access to advisors, strategic partners, and customers. Notable investments by Pritzker Group Venture Capital include high-profile companies such as Coinbase, SMS Assist, and SpotHero. The group focuses on sectors such as vertical SaaS, marketplaces, and healthtech, supporting companies from seed to growth stages. Their portfolio also includes companies like Cameo and G2 Crowd, showcasing their emphasis on innovative, scalable businesses. The private capital division of Pritzker Group focuses on acquiring and building leading middle-market companies in North America, with investments in industries like manufacturing, logistics, life sciences, and healthcare. Significant investments include firms like TMS International and STV Inc. Pritzker Group's asset management arm allocates capital globally to top-tier investment managers, providing diversified and strategic growth opportunities. Their comprehensive support for portfolio companies includes strategic guidance and leveraging their extensive network to accelerate growth and innovation​.

Progression is the TikTok alumni fund. We write first checks in visionary consumer tech founders. Consumer tech is at the beginning of a Super Cycle driven by AI. We are investing in a new wave of founders who are building AI native products that are transforming the lives of everyday consumers.

Prolog Ventures is a U.S.-based venture capital firm that focuses on early-stage investments in health, wellness, and sustainability. With offices in St. Louis and San Francisco, Prolog has a strong track record of backing startups that promote healthier lives and a healthier planet. Notable investments include Plum Organics, a pioneer in organic baby food, and Benson Hill, an agricultural tech innovator. Their portfolio spans consumer health, agtech, and wellness products. Prolog Ventures primarily targets startups in North America, with a particular emphasis on business models that enhance well-being through innovative ingredients, products, and delivery mechanisms. Their partnership with Lonza extends their reach into functional foods, dietary supplements, and personal care. Prolog's strategy revolves around investing in visionary companies that align with their ethos of supporting healthy living. The firm prefers to get involved early, often leading rounds with check sizes ranging from $500K to $5 million. They value long-term partnerships and often leverage their deep network in healthcare and consumer products to help portfolio companies scale. The team is led by co-founders Greg Johnson, Brian Clevinger, and Ilya Nykin, all of whom bring decades of expertise in life sciences and venture capital.

BBVA has a strong presence in the venture capital space through its BBVA Spark and Propel Venture Partners. BBVA Spark, launched in 2023, is focused on supporting high-growth companies, offering a range of financial products and services tailored to the needs of startups and scaleups. BBVA Spark integrates the bank’s Open Innovation initiatives to foster connections within the entrepreneurial ecosystem, facilitating collaborations between startups and established companies. Since its inception, BBVA Spark has invested €200 million in venture capital funds and provided over €100 million in financing across Spain and Mexico, supporting nearly 500 companies. Propel Venture Partners, established in 2016, is another key component of BBVA's venture capital strategy. Propel focuses on fintech and insurtech investments, with notable portfolio companies like Coinbase, Hippo, and Neon. BBVA has committed over $400 million to Propel, which helps bridge the gap between innovative fintech startups and growth opportunities in the Americas and beyond​.

PsyMed Ventures is a venture capital firm focused on transforming mental health treatment through innovative technologies, particularly in the areas of psychedelic medicine, neurotechnology, and precision psychiatry. Founded in 2020 by Dina Burkitbayeva, Greg Kubin, and Matias Serebrinsky, PsyMed Ventures began as a syndicate and has since evolved into a dedicated venture fund. In 2022, the firm launched a $25 million fund aimed at supporting early-stage startups that are pioneering new approaches to mental health. The fund's investments span a range of groundbreaking companies, including Freedom Biosciences and Delix Therapeutics, both of which are exploring the therapeutic potential of psychedelics. PsyMed's portfolio also includes companies working on advanced digital health platforms, novel drug formulations, and innovative neurotechnologies. PsyMed Ventures is particularly interested in companies at the pre-seed, seed, and Series A stages, believing that these early phases are where they can make the most significant impact. The firm emphasizes the importance of aligning with values-driven investors and entrepreneurs, recognizing that the mental health space requires long-term commitment and a collaborative approach.

Purple Orange Ventures (POV) is a Berlin-based, entrepreneur-led impact seed fund founded in 2012 by Gary Lin. Focused on leveraging science and technology, the fund is dedicated to solving some of the world’s most pressing challenges, specifically aiming to remove animals from the global food system and ensure sustainable food production. POV targets early-stage startups that are pioneering food-tech, agri-tech, and biotech innovations across the globe. POV invests primarily in pre-seed, seed, and Series A stages, with typical investments ranging from €100K to €1.5M. The fund backs mission-driven founders developing technologies in areas such as plant-based foods, lab-grown meat, and sustainable agriculture. Its portfolio includes companies like BLUU Seafood (lab-grown fish), Omni (plant-based pet food), and Change Foods (animal-free dairy). These startups are transforming the food industry by offering sustainable alternatives to traditional animal products. In addition to financial backing, Purple Orange Ventures provides its portfolio companies with business development support, operational expertise, and access to a network of industry experts to help accelerate growth and achieve market leadership. The firm’s mission reflects its commitment to creating a more sustainable, animal-free food ecosystem, positioning itself as a leader in the alternative protein and food technology sectors.

QED Investors, founded in 2007 by Nigel Morris and Frank Rotman, is a leading venture capital firm based in Alexandria, Virginia. The firm focuses exclusively on fintech and has made significant contributions to the growth of the financial services sector. QED has invested in over 200 companies across 16 countries, including notable names like Credit Karma, ClearScore, SoFi, Nubank, Remitly, and AvidXchange. QED recently closed two new funds totaling $925 million: an early-stage fund and a growth-stage fund, bringing their total assets under management to over $4 billion. These funds allow QED to continue its mission of investing in disruptive fintech companies globally, with a particular focus on the U.S., Europe, Latin America, India, and Southeast Asia​. The firm is renowned for its hands-on approach, leveraging the extensive operational experience of its partners to provide in-depth support to its portfolio companies. This includes strategic guidance, operational support, and access to a wide network of industry experts. QED is committed to building long-term relationships with entrepreneurs and playing an active role in their growth and success​.